Exome Asset Management »

Beigene Ltd call shares owned by Exome Asset Management

Quarter-by-quarter ownership of Beigene Ltd call shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Beigene Ltd call

Tip: Access up to 7 years of quarterly data

All positions including Beigene Ltd call held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beigene Ltd call by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 10k 296.97

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Enliven Therapeutics (ELVN)
Ionis Pharmaceuticals (IONS)
Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Cytokinetics Com New (CYTK)
Eli Lilly & Co. (LLY)
Alumis (ALMS)
Bridgebio Pharma (BBIO)
Vera Therapeutics Cl A (VERA)
Insmed Com Par $.01 (INSM)
Anthem (ELV)
Agios Pharmaceuticals (AGIO)
United Therapeutics Corporation (UTHR)

View all positions for Exome Asset Management

Top funds holding Beigene Ltd call

Exome Asset Management
IMC-Chicago
Simplex Trading

View all funds holding Beigene Ltd call